FINancial Toxicity and CAncer REcovery in YOUNG Adults

The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medicine Göttingen

Göttingen, Lower Saxony, 37075, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 to 39 years at the time of initial cancer diagnosis
Diagnosis of a malignant neoplasm
Receipt of oncological treatment at the University Medical Center Göttingen
Completion of primary cancer therapy at the time of study participation
Initial diagnosis between 2014 and 2024
Ability to provide informed consent
Sufficient German language skills to participate in a telephone interview and complete questionnaires

Exclusion criteria

Age below 18 years or above 39 years at the time of initial cancer diagnosis
No history of malignant disease
Ongoing primary cancer treatment at the time of study participation
Severe cognitive impairment or psychiatric condition preventing reliable participation
Insufficient German language proficiency to complete interviews or questionnaires
Withdrawal of informed consent

Treatment and study plan

Primary outcomes

Financial toxicity

Time frame: From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.

Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time.

Sponsors and collaborators

Lead sponsor

University Medical Center Goettingen

Other

Registry information

Acronym: FINCARE-Young

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jan 2, 2026
Registry last updated: Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.